Leading generics pharmaceutical company
Drug Approvals
Taj Pharmaceuticals Biotechnological Division has announced the research in order to create an mRNA vaccine against SARS-COV-2 (coronavirus). Development will be based on previous pipelines for mRNA-oncovaccines creation: an area where the company has a great expertise. The first animal studies are scheduled for the end of April.
We Taj Pharmaceuticals are in the midst of challenging times, brought upon us due to the unimaginable spread of COVID-19. As we grapple with this difficult and ever evolving situation, we wanted to reach out to make sure that you are doing okay and in case you needed any help. It is hard to think of a business that is not impacted by this pandemic, the effects of which we will all continue to feel for a long time. Taj Pharmaceuticals Limited company information | Taj Pharmaceuticals Key Executives | Taj Pharmaceuticals overview | Taj Pharmaceuticals
Coronavirus: Everything you need to know: China coronavirus: All you need to know – A new virus has killed 81 people in China and infected almost 3,000 people, with cases confirmed in several countries.
In Wuhan, China, where the novel coronavirus has killed at least 106 people and sickened 4,515 more, wearing face masks is mandatory. Half a world way in the US, major retailers are selling out of basic surgical masks amid panic from consumers.(So far, there have been five confirmed cases of coronavirus here.)Surgical masks are a […]
The analytical stages when a suspected issue is found in a product Contamination is arguably one of the greatest concerns in pharmaceutical manufacture, potentially compromising the final product. But when a problem is found, quick action by a Qualified Person (QP) and further analysis can make sure any problem is limited and patients are protected. […]
The first generic versions of the powerful blood thinner Eliquis (apixaban) were approved by the U.S. Food and Drug Administration on Monday. “Today’s approvals of the first generics of apixaban are an example of how the FDA’s generic drug program improves access to lower-cost, safe and high-quality medicines,” Dr. Janet Woodcock, director of the FDA’s […]
The U.S. Food and Drug Administration has approved three applications for first generics of Gilenya (fingolimod) capsules for the treatment of relapsing forms of multiple sclerosis (MS) in adult patients. “Approving safe and effective generics so patients have more treatment options continues to be a priority for the FDA,” said Janet Woodcock, M.D., director of […]
More drugs are in short supply for longer periods of time due to a fundamentally flawed pharmaceutical supply chain, according to a new report. The number of ongoing drug shortages has increased from 2017 to 2018 after declining from a peak in 2011. Shortages have also been lasting longer, in some cases more than eight […]
Consumer Reports examines why prescription drug prices are rising so sharply—and how to lower your drug costs As consumers, we know the difference between products we want and products we need. For luxury or convenience items, it’s easy enough to hold off on a purchase if our budget demands it—but for the things we can’t […]
Cost of branded drugs almost 14% below average in 50 countries surveyed Irish patients pay over six times the international average for generic drugs while branded medicines cost less than the average, according to a new survey. Ireland has the lowest price for the erectile dysfunction drug Viagra of the 50 countries included in the […]
